Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

147
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

617
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
617
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

111
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
111
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

175
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ContinuumAEP and the acquisition of competencies in Pediatrics.

Anales de pediatria·2025
Same author

Pediatric critical care admission after scoliosis surgery in children with underlying conditions: requirements, evolution and comparison with healthy children.

International journal of orthopaedic and trauma nursing·2025
Same author

Cardiac arrest in a previously healthy infant caused by secondary pseudohypoaldosteronism: Case report and literature review.

Medicina intensiva·2025
Same author

Why did you ask so many questions?

Palliative & supportive care·2025
Same author

Severe Mycoplasma Pneumoniae Infections During the 2023-2024 Outbreak: A Single-Center Descriptive Study in a Pediatric Intensive Care.

The Pediatric infectious disease journal·2025
Same author

Effectiveness and Safety of Cidofovir Treatment for Severe Adenovirus Pneumonia in Immunocompetent Pediatric Patients.

The Pediatric infectious disease journal·2025

Related Experiment Video

Updated: Dec 12, 2025

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
14:14

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR

Published on: December 6, 2014

17.2K

Normal fecal calprotectin levels in healthy children are higher than in adults and decrease with age.

Marta Velasco Rodríguez-Belvís1, Javier Francisco Viada Bris1, Carmen Plata Fernández2

  • 1Gastroenterology and Nutrition Department, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.

Paediatrics & Child Health
|August 9, 2020
PubMed
Summary

Pediatric fecal calprotectin (FC) levels are higher in infants and decrease with age. This study established normal FC ranges in healthy children, finding age is the primary factor influencing levels.

Keywords:
ChildrenFecal calprotectinHealthy

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

360
Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.1K

Related Experiment Videos

Last Updated: Dec 12, 2025

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR
14:14

Simultaneous Quantification of T-Cell Receptor Excision Circles TRECs and K-Deleting Recombination Excision Circles KRECs by Real-time PCR

Published on: December 6, 2014

17.2K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

360
Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis
07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.1K

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Biochemistry

Background:

  • Establishing reliable pediatric reference ranges for fecal calprotectin (FC) is crucial due to wide age-related variability.
  • Factors such as anthropometrics and feeding type may influence FC levels in children.

Purpose of the Study:

  • To establish normal fecal calprotectin (FC) levels in healthy children, stratified by age.
  • To investigate the influence of sex, gestational age, birth weight, delivery type, feeding type, and anthropometric data on pediatric FC values.

Main Methods:

  • A multicenter, cross-sectional, observational study included 395 healthy children under 18 years.
  • Exclusion criteria focused on conditions and factors that could affect FC levels, such as immunodeficiency, gastrointestinal disease, and medication use.

Main Results:

  • A significant negative correlation was observed between age and FC levels (Spearman's rho = -0.603, P<0.01).
  • The median FC level was 77.0 mcg/g (IQR 246).
  • No significant influence was found for sex, gestational age, birth weight, delivery type, feeding type, or anthropometric data on FC levels.

Conclusions:

  • Normal FC values in healthy children are higher than adult levels and decrease with age.
  • Current upper limits for FC in pediatric patients may need age-specific reconsideration.
  • Further research is needed to understand FC variations during infancy.